Mark T. Bertolini - 03 Apr 2023 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
Chief Executive Officer, Director
Signature
/s/Melissa Curtin, Attorney-in-Fact
Issuer symbol
OSCR
Transactions as of
03 Apr 2023
Transactions value $
$0
Form type
4
Filing time
05 Apr 2023, 17:24:36 UTC
Previous filing
03 Mar 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Performance Restricted Stock Units Award $0 +7.45M $0.00 7.45M 03 Apr 2023 Class A Common Stock 7.45M Direct F1, F2
transaction OSCR Restricted Stock Units Award $0 +2.87M $0.00 2.87M 03 Apr 2023 Class A Common Stock 2.87M Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The performance restricted stock units vest upon the Issuer's Class A common stock achieving certain specified price per share targets ranging from $11 to $39 per share.
F3 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F4 The restricted stock units vest in three equal annual installments beginning on April 3, 2024, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date.